New beginning, new direction for Health Data Management
Even as healthcare organizations deal with the ongoing challenges and the aftereffects of the pandemic, changes in healthcare delivery wait in the wings or must be managed right now.
Even as healthcare organizations deal with the ongoing challenges and the aftereffects of the pandemic, changes in healthcare delivery wait in the wings or must be managed right now.
As Health Data Management wraps up 27 years of reporting on the healthcare information technology industry today, it gives me a chance to pause and reflect, and to look hopefully toward the future for the industry.
As part of the global effort to manage and contain the coronavirus response, two global health standards organizations have introduced new content.
Radiologists getting an assist from artificial intelligence can detect more breast cancer—with a reduced rate of false positive incidents—from mammography images.
Researchers at two companies say they have developed an artificial intelligence platform intended to aid pathologists who use images to classify subtypes of lung cancer.
Community hospitals—smaller providers generally believed to be late to implement electronic health records systems—are now taking a closer look at whether they’re getting a return on their digital investment.
A group representing many stakeholders within the healthcare industry is pushing to set time requirements intended to speed the prior authorization process.
Rising pressure for combining organizations to produce quick benefits makes IT analysis critical in the earliest plans for consolidation.
Memorial Sloan Kettering Cancer Center has hired a former technology executive from the United Nations to take the lead role for IT operations at the healthcare organization.
The use of technology will be key to the success of Walmart health facilities that the retail giant is beginning to roll out.
Most Americans want personalized, actionable healthcare information, but not if it puts their personal health data in peril.
A London private equity investment firm has purchased a stake in Intelerad Medical Systems, a Montreal-based company that develops medical imaging software and workflow solutions.